CN · Field Sheet
FIELD SHEET — KRILL OIL MFI-KRILLO-20261014-FS
Survey index / KRILL OIL

Krill oil.

Euphausia superba, Euphausia pacifica, Euphausia crystallorophias
Antarctic krill lipid extract; omega-3 phospholipid and joint literature.
SEALED MFI-KRILLO-20261014-FS · RELEASED 2026-10-14
SHEET FINGERPRINTMFI-KRILLO-20261014-FS
400INCLUDED
1,872EXCLUDED
108DUPLICATE
101NON-TRANSFERABLE
0OUT OF CUTOFF
Survey totalsScroll ↓
2,481records surveyed
400studies
31claims graded
213observations
8,671graph nodes

Claim records

2 shown · bounded preview
RECORD PREVIEW · FIELD RECORD ×2BOUNDED — REAL RELEASED DATA
CLAIM · CLM-347049ae357f653aGRADE VERY_LOW
krill oil constituents — cholesterol
direction BENEFIT · dose 100 mg/kg; 2 g; 4 g · duration 10 weeks; 28 day; 28 days; 6 weeks; 8 weeks
Grade basis — weakest-link ceilings
HIGHdesign
LOWdirectness
LOWextraction
VERY_LOWconfidence
MODERATEmethodology
MODERATEconsistency
MODERATEnumeric
18bound studies
Bound studies (4 shown of 18)
STU-05d71ddf0224651f
RCT · HUMAN · 2013 · RoB SOME_CONCERNS
2 endpoints
STU-0d6e81a799d70710
ANIMAL · ANIMAL · 2021 · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-22c1ad34f81a696e
ANIMAL · ANIMAL · 2014 · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-3dc116fcfd57c55a
UNSPECIFIED · HUMAN · 2013 · RoB NOT_ASSESSABLE
2 endpoints
Quantitative observations
p_value p = 0.0321 · validated
dose 4 g · validated
Opposition screen
SCREEN · 24 candidates considered · 0 bound as opposing
SYNTHESIS SYN-14e350e548aa66 — outcome QUALITATIVE_ONLY · BENEFIT ×18 · not_assessed_quantitatively · 18 members
PROVENANCE → epmc:24098072, epmc:34507719, epmc:24816553 · PKG acd7a15d0e452848…
CLAIM · CLM-0fcadb3351bb0b8dGRADE VERY_LOW
krill oil constituents — inflammation
direction BENEFIT · dose 250 mg/kg; 4 g; 500 mg · duration 24 weeks; 28 day; 8 weeks; 90 days
Grade basis — weakest-link ceilings
HIGHdesign
LOWdirectness
LOWextraction
VERY_LOWconfidence
MODERATEmethodology
MODERATEconsistency
MODERATEnumeric
20bound studies
Bound studies (4 shown of 20)
STU-0d6e81a799d70710
ANIMAL · ANIMAL · 2021 · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-2c53d6cbf86978dd
ANIMAL · ANIMAL · 2021 · 24 weeks · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-2cacbac4b076f9c0
IN_VITRO · IN_VITRO · 2026 · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-42b8285bbade0189
ANIMAL · ANIMAL · 2021 · RoB INSUFFICIENT_INFORMATION
3 endpoints
Quantitative observations
duration 24 weeks · failed extraction
effect reduced (by 68% · failed extraction
Opposition screen
SCREEN · 31 candidates considered · 0 bound as opposing
SYNTHESIS SYN-4d3d82f5726457 — outcome QUALITATIVE_ONLY · BENEFIT ×20 · not_assessed_quantitatively · 20 members
PROVENANCE → epmc:34507719, epmc:42348265, epmc:34573047 · PKG acd7a15d0e452848…
Bounded preview — representative records only. The full release ships 31 claims and 213 observations.